(Q39258049)

10 September 2017

title

Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections (English)

1 reference

10 September 2017

6

Hans-Dieter Klenk

1 reference

10 September 2017

author name string

Eva Böttcher-Friebertshäuser

1

1 reference

10 September 2017

Yinghui Lu

2

1 reference

10 September 2017

Daniela Meyer

3

1 reference

10 September 2017

Frank Sielaff

4

1 reference

10 September 2017

Torsten Steinmetzer

5

1 reference

10 September 2017

Wolfgang Garten

7

1 reference

10 September 2017

language of work or name

English

0 references

publication date

13 October 2012

1 reference

10 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

10 September 2017

volume

30

1 reference

10 September 2017

issue

51

1 reference

10 September 2017

page(s)

7374-7380

1 reference

The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Proteolytic activation of the 1918 influenza virus hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Influenza hemagglutinin and neuraminidase membrane glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Cleavage Activation of the Influenza Virus Hemagglutinin and Its Role in Pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Combination chemotherapy for influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Preservation of in vitro function of platelets stored in the presence of a synthetic dual inhibitor of factor Xa and thrombin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Phenotypic analysis of mice lacking the Tmprss2-encoded protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Activation of influenza A viruses by trypsin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

New low-viscosity overlay medium for viral plaque assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Identification of the First Low-Molecular-Weight Inhibitors of Matriptase-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

Suppression of Influenza Virus Replication in Infected Mice by Protease Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.001

10.1016/J.VACCINE.2012.10.001

7 January 2021

Identifiers

DOI

1 reference

release_4avhd7474vdnbpevtqdahwqr7u

10 September 2017

Fatcat ID

0 references

1 reference